Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ UR-144 5-Pentanoic acid metabolite-D5 (indole-D5), 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco S0901ML

Catalog No. 01-001-991


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

An internal standard suitable for quantitation of UR-144 5-pentanoic acid metabolite levels using LC-MS/MS or GC/MS for synthetic cannabinoid testing methods in forensic analysis, clinical toxicology, or urine drug testing. UR-144 5-pentanoic acid metabolite is a primary urinary metabolite of UR-144, a third generation synthetic cannabinoid that has seen wide popularity in illicit drug markets since late 2012. For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork.
Specifications

Specifications

67-56-1
UN 1230 - class 3 - PG 2 - Methanol, solution
346.47
1 mL
C21H22D5NO3
100 μg/mL in methanol
Ampule
9.7°C (49.5°F) - closed cup
Safety and Handling

Safety and Handling

H331-H370

H311

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation